Literature DB >> 10653442

Treatment of edematous disorders with diuretics.

A Rasool1, P M Palevsky.   

Abstract

Generalized edema results from alterations in renal sodium homeostasis that ultimately result in an expansion of extracellular fluid volume and accumulation of interstitial fluid. The common edematous disorders include congestive heart failure, cirrhosis, nephrotic syndrome, and renal insufficiency. The abnormalities of sodium homeostasis contributing to edema formation in each condition are discussed. Management of volume homeostasis, with an emphasis on the role of diuretic therapy, is reviewed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653442     DOI: 10.1097/00000441-200001000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure.

Authors:  Hong Zheng; Xuefei Liu; Neeru M Sharma; Yulong Li; Rainer U Pliquett; Kaushik P Patel
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

2.  Increased renal ENaC subunits and sodium retention in rats with chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; U S Rao; Kaushik P Patel
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-15

Review 3.  Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.

Authors:  Kaushik P Patel; Kenichi Katsurada; Hong Zheng
Journal:  Circ Res       Date:  2022-05-12       Impact factor: 23.213

Review 4.  New role for plasmin in sodium homeostasis.

Authors:  Christopher J Passero; Rebecca P Hughey; Thomas R Kleyman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

5.  Renal denervation improves sodium excretion in rats with chronic heart failure: effects on expression of renal ENaC and AQP2.

Authors:  Hong Zheng; Xuefei Liu; Kenichi Katsurada; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-06       Impact factor: 4.733

6.  Initial experience with conivaptan use in critically ill infants with cardiac disease.

Authors:  Ryan C Jones; Surender Rajasekaran; Mark Rayburn; Joseph D Tobias; Robert M Kelsey; Glenn T Wetzel; Antonio G Cabrera
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

7.  Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome.

Authors:  Akiko Matsuda; Ken Tsuchiya; Yasuko Yabuki; Masayo Naito; Minako Koike; Wako Yumura; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.